What are Larimar Therapeutics Inc's Business Segments?

Larimar Therapeutics Inc is a biotechnology company that focuses on discovering and developing innovative treatments for rare diseases. The company has a range of products and services aimed at addressing the unmet medical needs of patients with rare diseases.

Segments:

Larimar Therapeutics operates across two main segments:

1) Drug Discovery and Development: This segment focuses on the discovery, development, and commercialization of innovative therapies for rare diseases. The company's pipeline consists of two lead product candidates, CTI-1601 and CTI-1501, which target Friedreich's ataxia (FA) and Duchenne muscular dystrophy (DMD), respectively.

2) Gene Therapy: This segment focuses on the development and commercialization of gene therapies for rare diseases. The company has a proprietary gene therapy platform that includes novel vectors and delivery technologies for the targeted and efficient delivery of therapeutics.

Products:

1) CTI-1601: This is Larimar Therapeutics' lead product candidate, which is being developed for the treatment of FA, a rare genetic disease that causes progressive damage to the nervous system and heart. CTI-1601 is a recombinant fusion protein that is designed to increase the production of frataxin, a protein that is deficient in patients with FA.

2) CTI-1501: This is another lead product candidate developed by Larimar Therapeutics, which is being developed for the treatment of DMD, a rare genetic disorder that causes progressive muscle weakness and wasting. CTI-1501 is a recombinant fusion protein that is designed to increase the production of utrophin, a protein that can compensate for the loss of dystrophin, the protein that is deficient in patients with DMD.

Services:

1) Gene Therapy Platform: Larimar Therapeutics has a proprietary gene therapy platform that includes novel vectors and delivery technologies for the targeted and efficient delivery of therapeutics. The company offers this platform as a service to other biotechnology and pharmaceutical companies, enabling them to develop and commercialize their own gene therapies.

2) Drug Discovery and Development Services: In addition to developing its own product candidates, Larimar Therapeutics also offers drug discovery and development services to other companies. These services include target identification, hit-to-lead optimization, preclinical development, and clinical development. The company's expertise in rare diseases makes it a valuable partner for companies looking to develop innovative therapeutics for rare diseases.